Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are associated with neurological phenotypes in humans
Douglas R. Smith, Christine M. Stanley, Theodore Foss, et al.
PLoS ONE (2017) Vol. 12, Iss. 11, pp. e0187926-e0187926
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma
Gao‐Min Liu, Huadong Zeng, Caiyun Zhang, et al.
Cancer Cell International (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 147
The Endocannabinoid System of Animals
Robert Silver
Animals (2019) Vol. 9, Iss. 9, pp. 686-686
Open Access | Times Cited: 101
Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists
Elise Wouters, Jolien Walraed, Samuel D. Banister, et al.
Biochemical Pharmacology (2019) Vol. 169, pp. 113623-113623
Closed Access | Times Cited: 79
Mouse and rat ultrasonic vocalizations in neuroscience and neuropharmacology: State of the art and future applications
Marika Premoli, Susanna Pietropaolo, Markus Wöhr, et al.
European Journal of Neuroscience (2023) Vol. 57, Iss. 12, pp. 2062-2096
Open Access | Times Cited: 40
Neurological and psychiatric comorbidities of migraine: Concepts and future perspectives
Nadine Pelzer, Irene de Boer, Arn M. J. M. van den Maagdenberg, et al.
Cephalalgia (2023) Vol. 43, Iss. 6
Open Access | Times Cited: 31
FMR1 and Autism, an Intriguing Connection Revisited
William Fyke, Milen Velinov
Genes (2021) Vol. 12, Iss. 8, pp. 1218-1218
Open Access | Times Cited: 42
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
João Francisco Cordeiro Pedrazzi, Frederico Rogério Ferreira, Danyelle Silva-Amaral, et al.
Psychopharmacology (2022) Vol. 239, Iss. 9, pp. 2713-2734
Closed Access | Times Cited: 31
Cannabinoids and the endocannabinoid system in fibromyalgia: A review of preclinical and clinical research
Stephanie Bourke, Anne Katrin Schlag, Saoirse E. O’Sullivan, et al.
Pharmacology & Therapeutics (2022) Vol. 240, pp. 108216-108216
Open Access | Times Cited: 28
Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment
Joseph Palumbo, Brian F. Thomas, Dejan B. Budimirovic, et al.
Journal of Neurodevelopmental Disorders (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Targeted gene sequencing in 6994 individuals with neurodevelopmental disorder with epilepsy
Henrike Heyne, Mykyta Artomov, Florian Battke, et al.
Genetics in Medicine (2019) Vol. 21, Iss. 11, pp. 2496-2503
Open Access | Times Cited: 53
Emerging Role of (Endo)Cannabinoids in Migraine
Pinja Leimuranta, Leonard Khiroug, Rashid Giniatullin
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 52
Maternal high-fat diet impairs leptin signaling and up-regulates type-1 cannabinoid receptor with sex-specific epigenetic changes in the hypothalamus of newborn rats
Mariana M. Almeida, Camilla P. Dias-Rocha, Clara F. Reis-Gomes, et al.
Psychoneuroendocrinology (2019) Vol. 103, pp. 306-315
Closed Access | Times Cited: 52
Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder
Mingyang Zou, Yu Liu, Shu Xie, et al.
Open Biology (2021) Vol. 11, Iss. 2
Open Access | Times Cited: 34
Sex differences in the expression of the endocannabinoid system within V1M cortex and PAG of Sprague Dawley rats
Aidan Levine, Erika Liktor‐Busa, Austin A. Lipinski, et al.
Biology of Sex Differences (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 34
Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders
Daniela Navarro, Ani Gasparyan, Francisco Navarrete, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4764-4764
Open Access | Times Cited: 24
Comprehending and improving cannabis specialized metabolism in the systems biology era
Paco Romero, Arnau Peris, K. Vergara, et al.
Plant Science (2020) Vol. 298, pp. 110571-110571
Closed Access | Times Cited: 36
Roles and mechanisms of ankyrin-G in neuropsychiatric disorders
Sehyoun Yoon, Nicolas H. Piguel, Peter Penzes
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 7, pp. 867-877
Open Access | Times Cited: 21
Therapeutic potential of CBD in Autism Spectrum Disorder
João Francisco Cordeiro Pedrazzi, Lucas Hassib, Frederico Rogério Ferreira, et al.
International review of neurobiology (2024), pp. 149-203
Closed Access | Times Cited: 4
Cannabis in Veterinary Medicine: Cannabinoid Therapies for Animals
Joshua A. Hartsel, Kyle Boyar, Andrew Pham, et al.
Springer eBooks (2019), pp. 121-155
Closed Access | Times Cited: 34
Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story
Emilia Carbone, Antonia Manduca, Claudia Cacchione, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 121, pp. 128-143
Closed Access | Times Cited: 29
Communication and social interaction in the cannabinoid‐type 1 receptor null mouse: Implications for autism spectrum disorder
William Fyke, Marika Premoli, Victor Echeverry Alzate, et al.
Autism Research (2021) Vol. 14, Iss. 9, pp. 1854-1872
Open Access | Times Cited: 26
Resting State Brain Networks under Inverse Agonist versus Complete Knockout of the Cannabinoid Receptor 1
Hui Li, Qiong Ye, Da Wang, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 8, pp. 1669-1683
Closed Access | Times Cited: 3
Endocannabinoid-serotonin systems interaction in health and disease
Roberto Colangeli, G. Campbell Teskey, Giuseppe Di Giovanni
Progress in brain research (2021), pp. 83-134
Closed Access | Times Cited: 23
Therapeutic potential of cannabidivarin for epilepsy and autism spectrum disorder
Erica Zamberletti, Tiziana Rubino, Daniela Parolaro
Pharmacology & Therapeutics (2021) Vol. 226, pp. 107878-107878
Closed Access | Times Cited: 23
The role of the endocannabinoid system in autism spectrum disorders: Evidence from mouse studies
Susanna Pietropaolo, Luigi Bellocchio, Inés Bouzón‐Arnáiz, et al.
Progress in molecular biology and translational science (2020), pp. 183-208
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top